Edition:
United States

aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

2.40USD
20 Apr 2018
Change (% chg)

$-0.05 (-2.04%)
Prev Close
$2.45
Open
$2.45
Day's High
$2.45
Day's Low
$2.40
Volume
4,250
Avg. Vol
8,293
52-wk High
$6.45
52-wk Low
$2.33

Chart for

About

aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based... (more)

Overall

Beta: --
Market Cap(Mil.): $75.88
Shares Outstanding(Mil.): 29.76
Dividend: --
Yield (%): --

Financials

  LIFE.OQ Industry Sector
P/E (TTM): -- 185.16 33.25
EPS (TTM): -1.89 -- --
ROI: -63.87 -0.71 13.13
ROE: -75.89 -2.76 14.96

BRIEF-Atyr Pharma Q4 Loss Per Share $0.39

* ATYR PHARMA ANNOUNCES FOURTH QUARTER AND YEAR-END 2017 OPERATING RESULTS AND PROVIDES CORPORATE UPDATE

Mar 19 2018

BRIEF-Atyr Pharma Says On Dec 22, Co Entered Into Amendment To Loan And Security Agreement Dated As Of Nov 18, 2016

* ATYR PHARMA SAYS ON DEC 22, CO ENTERED INTO AMENDMENT TO LOAN AND SECURITY AGREEMENT DATED AS OF NOV 18, 2016 - SEC FILING

Dec 22 2017

BRIEF-aTyr Pharma reports qtrly ‍net loss per share, basic and diluted $0.43​

* aTyr Pharma announces third quarter 2017 operating results and provides corporate update

Nov 14 2017

Earnings vs. Estimates